abstract |
The invention relates to derivatives of 1,3,4-oxadiazole-2 (3H) -one, corresponding to the general formula given in the description, in the form of pure enantiomers or a mixture of enantiomers, including racemic mixtures, as well as their salts resulting from the addition of pharmaceutically acceptable acids. Therapeutic use. |